Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Aevi Genomic Medicine, Inc. (CERC) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/13/2018 8-K Quarterly results
Docs: "Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update",
"Presentation Deck"
08/09/2017 8-K Quarterly results
Docs: "Aevi Genomic Medicine Reports Second Quarter 2017 Financial Results"
05/10/2017 8-K Form 8-K - Current report
03/09/2017 8-K Form 8-K - Current report
11/03/2016 8-K Quarterly results
Docs: "– November 3, 2016 -- Medgenics, Inc.",
"Slide Presentation (furnished pursuant to Item 7.01)"
08/04/2016 8-K Quarterly results
Docs: "Medgenics, Inc. today announced second quarter 2016 financial results and provided a business update. “We are very pleased with the Company’ s accomplishments during the first half of 2016,” stated Mike Cola, CEO of Medgenics. “We have advanced NFC-1 into the clinic in mGluR+ ADHD with data expected in 2016, and we will soon initiate a trial in patients with 22q11.2 Deletion Syndrome. The announcement of our collaboration with Kyowa Hakko Kirin demonstrated the Company’ s ability to advance our growing pipeline of opportunities, and the successful fundraising we recently completed will further enable us to accelerate the development of these programs. We remain steadfast in our focus on developing innovative, genomically-based, best-in-class therapies focused on improving the lives of chi...",
"Slide Presentation (furnished pursuant to Item 7.01)"
05/10/2016 8-K Quarterly results
Docs: "Rapid enrollment in phenotype/genotype study of mGluR positive ADHD patients",
"Slide Presentation (furnished pursuant to Item 7.01)"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy